Back
Genmab AS 10K Form
Buy
60
GMAB
Genmab AS
Last Price:
$22.35
Seasonality Move:
16.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GMAB News And Ratings
See the #1 stock for the next 7 days that we like better than GMAB
GMAB Financial Statistics
Sales & Book Value
Annual Sales: | $3.1B |
---|---|
Cash Flow: | $353M |
Price / Cash Flow: | 13.33 |
Annual Sales: | $8.06 |
Price / Book: | 2.77 |
Profitability
EPS (TTM): | 1.75130 |
---|---|
Net Income (TTM): | $1.1B |
Gross Margin: | $3B |
Return on Equity: | 23.85% |
Return on Assets: | 19.92% |
Genmab AS Earnings Forecast
Key Genmab AS Financial Ratios
-
The Gross Profit Margin over the past 18 years for GMAB is 95.42%.
-
The Selling, General & Administrative Expenses for GMAB have been equal to 17.61% of Gross Profit Margin.
-
The Research & Development expenses have been 45.28% of Revenue.
-
The Interest Expense is 1.53% of Operating Income.
-
The Net Earning history of GMAB is 36.44% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 16 years.
Genmab AS Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | GMAB |
Website: | genmab.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.25 |
Quick Ratio: | 5.24 |
Price-to-Earnings
Trailing P/E Ratio: | 12.69 |
---|---|
Forward P/E Ratio: | 12.67 |